Published in
Elsevier, Enfermedades Infecciosas y Microbiología Clínica, 3(37), p. 151-159, 2019
DOI: 10.1016/j.eimc.2018.04.010
Enfermedades infecciosas y microbiologia clinica (English ed.), 3(37), p. 151-159, 2019
DOI: 10.1016/j.eimce.2018.04.019
Links
Tools
Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adults
Journal article published in 2018 by
José Antonio Pérez-Molina,
Jose Antonio Perez-Molina,
Pérez Molina Ja 
,
Esteban Martínez,
Antonio Javier Blasco,
José Ramón Arribas,
Pere Domingo,
José Antonio Iribarren,
Pablo Lazaro,
Hernando Knobel,
Jose Lopez-Aldeguer,
José M. Miró,
Pablo Lázaro,
Blasco Aj,
Santiago Moreno
and other authors.
,
Esteban Martínez,
Antonio Javier Blasco,
José Ramón Arribas,
Pere Domingo,
José Antonio Iribarren,
Pablo Lazaro,
Hernando Knobel,
Jose Lopez-Aldeguer,
José M. Miró,
Pablo Lázaro,
Blasco Aj,
Santiago Moreno
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 